{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:05:22Z","timestamp":1781197522524,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent studies have suggested an association between prenatal and early life antibiotics with adverse neurodevelopmental outcomes in children. As antibiotics during pregnancy are commonly prescribed, our aim was to estimate the association the groups of antibiotics prescribed for GBS during pregnancy the risk of neurodevelopmental outcomes in children. This population-based cohort study included all live births in Sweden from 2006 to 2016 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091,066,777). Individual informed consent was not required, as the study used data from national registers and involved no direct participant contact. Using multivariable Cox Regression models and GEE models for secondary assessment we measured the association between seven first line treatment GBS antibiotics during pregnancy and (1) intellectual disability, (2) cerebral palsy, (3) autism spectrum disorder (ASD), and (4) attention deficit hyperactivity disorder (ADD\/ADHD) as recorded in high-quality Swedish registers. GBS antibiotics were prescribed to 22.1% of mothers included. We found no association between GBS antibiotics and the risk of intellectual disability. However, a modest association was observed for cerebral palsy (aHR 1.17, 95%CI 1.06\u20131.29), ASD (aHR 1.12, 95%CI 1.07\u20131.17), and ADHD\/ADD (aHR 1.17, 95%CI 1.12\u20131.22). This association was also seen when only including children born at term, and only children of mothers without autism spectrum disorder or ADHD diagnosis. The results were model dependent, as GEE models did not always show the same associations. Although the results could be affected by residual confounding or confounding by indication (as GBS infection has been associated with neurodevelopmental outcomes), they highlight the need for further studies on GBS antibiotic use during pregnancy, increased antibiotic stewardship with individual risk assessment and other treatment options for GBS, when needed.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-57533-y","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:13:37Z","timestamp":1781194417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Group B Streptococcus antibiotics treatment during pregnancy and the risk of four neurodevelopmental outcomes in Swedish children"],"prefix":"10.1038","volume":"16","author":[{"given":"Unnur","family":"Gudnadottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Orwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Cam Tu","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Blaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelle","family":"Moley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Elfvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Wannerberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"57533_CR1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jad.2023.07.071","volume":"339","author":"G Ayano","year":"2023","unstructured":"Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L. & Alati, R. The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. J. Affect. Disord. 339, 860\u2013866 (2023).","journal-title":"J. Affect. Disord"},{"key":"57533_CR2","doi-asserted-by":"publisher","first-page":"1122009","DOI":"10.3389\/fpubh.2023.1122009","volume":"11","author":"BO Olusanya","year":"2023","unstructured":"Olusanya, B. O. et al. Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review. Front. Public. Health. 11, 1122009 (2023).","journal-title":"Front. Public. Health"},{"key":"57533_CR3","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/dmcn.15346","volume":"64","author":"S McIntyre","year":"2022","unstructured":"McIntyre, S. et al. Global prevalence of cerebral palsy: A systematic analysis. Dev. Med. Child. Neurol. 64, 1494\u20131506 (2022).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57533_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/aur.2696","volume":"15","author":"J Zeidan","year":"2022","unstructured":"Zeidan, J. et al. Global prevalence of autism: A systematic review update. Autism Res. 15, 778\u2013790 (2022).","journal-title":"Autism Res."},{"key":"57533_CR5","unstructured":"Socialstyrelsen Diagnostik Och L\u00e4kemedelsbehandling Vid Adhd. (2023)."},{"key":"57533_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s11689-024-09576-3","volume":"16","author":"M Morinaga","year":"2024","unstructured":"Morinaga, M. et al. Changes in the prevalence of intellectual disability among 10-year-old children in Sweden during 2011 through 2021: a total population study. J. Neurodev Disord. 16, 58 (2024).","journal-title":"J. Neurodev Disord"},{"key":"57533_CR7","doi-asserted-by":"publisher","first-page":"e038453","DOI":"10.1136\/bmjopen-2020-038453","volume":"10","author":"A Joud","year":"2020","unstructured":"Joud, A., Sehlstedt, A., Kallen, K., Westbom, L. & Rylander, L. Associations between antenatal and perinatal risk factors and cerebral palsy: a Swedish cohort study. BMJ Open. 10, e038453 (2020).","journal-title":"BMJ Open."},{"key":"57533_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10803-020-04563-8","volume":"51","author":"P Linnsand","year":"2021","unstructured":"Linnsand, P., Gillberg, C., Nilses, A., Hagberg, B. & Nygren, G. A. High Prevalence of Autism Spectrum Disorder in Preschool Children in an Immigrant, Multiethnic Population in Sweden: Challenges for Health Care. J. Autism Dev. Disord. 51, 538\u2013549 (2021).","journal-title":"J. Autism Dev. Disord"},{"key":"57533_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40264-023-01297-1","volume":"46","author":"LL Njotto","year":"2023","unstructured":"Njotto, L. L. et al. Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study. Drug Saf. 46, 467\u2013478 (2023).","journal-title":"Drug Saf."},{"key":"57533_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41575-023-00864-2","volume":"21","author":"O Koren","year":"2024","unstructured":"Koren, O., Konnikova, L., Brodin, P., Mysorekar, I. U. & Collado, M. C. The maternal gut microbiome in pregnancy: implications for the developing immune system. Nat. Rev. Gastroenterol. Hepatol. 21, 35\u201345 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"57533_CR11","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.mib.2022.102173","volume":"69","author":"HP Browne","year":"2022","unstructured":"Browne, H. P., Shao, Y. & Lawley, T. D. Mother\u2013infant transmission of human microbiota. Curr. Opin. Microbiol. 69, 102173 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"57533_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12916-024-03617-3","volume":"22","author":"C Love","year":"2024","unstructured":"Love, C. et al. Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms. BMC Med. 22, 393 (2024).","journal-title":"BMC Med."},{"key":"57533_CR13","doi-asserted-by":"crossref","unstructured":"Biagioli, V., Volpedo, G., Riva, A., Mainardi, P. & Striano, P. From Birth to Weaning: A Window of Opportunity for Microbiota. Nutrients 16, (2024).","DOI":"10.3390\/nu16020272"},{"key":"57533_CR14","doi-asserted-by":"publisher","first-page":"109491","DOI":"10.1016\/j.neuropharm.2023.109491","volume":"231","author":"F Damiani","year":"2023","unstructured":"Damiani, F., Cornuti, S. & Tognini, P. The gut-brain connection: Exploring the influence of the gut microbiota on neuroplasticity and neurodevelopmental disorders. Neuropharmacology 231, 109491 (2023).","journal-title":"Neuropharmacology"},{"key":"57533_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12915-023-01709-9","volume":"21","author":"A Husso","year":"2023","unstructured":"Husso, A. et al. Impacts of maternal microbiota and microbial metabolites on fetal intestine, brain, and placenta. BMC Biol. 21, 207 (2023).","journal-title":"BMC Biol."},{"key":"57533_CR16","doi-asserted-by":"publisher","unstructured":"Beier, M. A. et al. Early Childhood Antibiotics and Chronic Pediatric Conditions: A Retrospective Cohort Study. J. Infect. Dis. jiaf191 https:\/\/doi.org\/10.1093\/infdis\/jiaf191 (2025).","DOI":"10.1093\/infdis\/jiaf191"},{"key":"57533_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mayocp.2020.07.019","volume":"96","author":"Z Aversa","year":"2021","unstructured":"Aversa, Z. et al. Association of Infant Antibiotic Exposure With Childhood Health Outcomes. Mayo Clin. Proc. 96, 66\u201377 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"57533_CR18","doi-asserted-by":"publisher","first-page":"2206505","DOI":"10.1080\/19490976.2023.2206505","volume":"15","author":"M Tian","year":"2023","unstructured":"Tian, M. et al. Maternal microbe-specific modulation of the offspring microbiome and development during pregnancy and lactation. Gut Microbes. 15, 2206505 (2023).","journal-title":"Gut Microbes"},{"key":"57533_CR19","doi-asserted-by":"publisher","first-page":"1045865","DOI":"10.3389\/fneur.2022.1045865","volume":"13","author":"Q Tao","year":"2022","unstructured":"Tao, Q. et al. Prenatal exposure to antibiotics and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. Front. Neurol. 13, 1045865 (2022).","journal-title":"Front. Neurol."},{"key":"57533_CR20","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00213-023-06351-5","volume":"240","author":"RF Slykerman","year":"2023","unstructured":"Slykerman, R. F., Neumann, D., Underwood, L., Hobbs, M. & Waldie, K. E. Age at first exposure to antibiotics and neurodevelopmental outcomes in childhood. Psychopharmacol. Berl. 240, 1143\u20131150 (2023).","journal-title":"Psychopharmacol. Berl"},{"key":"57533_CR21","doi-asserted-by":"publisher","unstructured":"Orwa SA, Gudnadottir U, Boven A, Pauwels I, Versporten A, Vlieghe E, Brusselaers N. Global prevalence of antibioticconsumption during pregnancy: A systematic review and meta-analysis. J Infect. 2024 Aug;89(2):106189. Epub 2024 Jun 4. PMID: 38844084. https:\/\/doi.org\/10.1016\/j.jinf.2024.106189","DOI":"10.1016\/j.jinf.2024.106189"},{"key":"57533_CR22","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","volume":"10","author":"BP Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, B. P. et al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 10, e807\u2013e819 (2022).","journal-title":"Lancet Glob Health"},{"key":"57533_CR23","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/cid\/cix658","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell, N. J. et al. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin. Infect. Dis. 65, S100\u2013S111 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"57533_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/00016340801908759","volume":"87","author":"E Barcaite","year":"2008","unstructured":"Barcaite, E. et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet. Gynecol. Scand. 87, 260\u2013271 (2008).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"57533_CR25","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1093\/cid\/cix653","volume":"65","author":"JE Lawn","year":"2017","unstructured":"Lawn, J. E. et al. Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? Clin. Infect. Dis. 65, S89\u2013S99 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"57533_CR26","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix655","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell, N. J. et al. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin. Infect. Dis. 65, S152\u2013S159 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"57533_CR27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/ajo.13370","volume":"61","author":"K Braye","year":"2021","unstructured":"Braye, K., Ferguson, J., Ball, J. & Foureur, M. Intrapartum antibiotic prophylaxis for women who are screened positive for group B streptococcal colonisation: Clinical compliance with the guideline. Aust N Z. J. Obstet. Gynaecol. 61, 870\u2013875 (2021).","journal-title":"Aust N Z. J. Obstet. Gynaecol."},{"key":"57533_CR28","doi-asserted-by":"publisher","first-page":"102748","DOI":"10.1016\/j.eclinm.2024.102748","volume":"74","author":"TJR Panneflek","year":"2024","unstructured":"Panneflek, T. J. R. et al. Intrapartum antibiotic prophylaxis to prevent Group B streptococcal infections in newborn infants: a systematic review and meta-analysis comparing various strategies. EClinicalMedicine 74, 102748 (2024).","journal-title":"EClinicalMedicine"},{"key":"57533_CR29","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/aogs.13211","volume":"96","author":"S Hakansson","year":"2017","unstructured":"Hakansson, S., Lilja, M., Jacobsson, B. & Kallen, K. Reduced incidence of neonatal early-onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort. Acta Obstet. Gynecol. Scand. 96, 1475\u20131483 (2017).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"57533_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/00016340701802888","volume":"87","author":"S H\u00e5kansson","year":"2008","unstructured":"H\u00e5kansson, S. et al. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet. Gynecol. Scand. 87, 50\u201358 (2008).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"57533_CR31","doi-asserted-by":"publisher","unstructured":"Liu Y, Ai H. Current research update on group B streptococcal infection related to obstetrics and gynecology. FrontPharmacol. 2024 Jun 17;15:1395673. PMID: 38953105; PMCID: PMC11215423. https:\/\/doi.org\/10.3389\/fphar.2024.1395673","DOI":"10.3389\/fphar.2024.1395673"},{"key":"57533_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/archdischild-2020-320638","volume":"106","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay, S. et al. Intrapartum group B Streptococcal prophylaxis and childhood weight gain. Arch. Child. Fetal Neonatal Ed. 106, 649\u2013656 (2021).","journal-title":"Arch. Child. Fetal Neonatal Ed."},{"key":"57533_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark, B. et al. The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 16, 726\u2013735 (2007).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"57533_CR34","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/aogs.13570","volume":"98","author":"E Wolgast","year":"2019","unstructured":"Wolgast, E., Lindh-\u00c5strand, L. & Lilliecreutz, C. Women\u2019s perceptions of medication use during pregnancy and breastfeeding\u2014A Swedish cross-sectional questionnaire study. Acta Obstet. Gynecol. Scand. 98, 856\u2013864 (2019).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"57533_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/WCO.0000000000000714","volume":"32","author":"T May","year":"2019","unstructured":"May, T., Adesina, I., McGillivray, J. & Rinehart, N. J. Sex differences in neurodevelopmental disorders. Curr. Opin. Neurol. 32, 622 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"57533_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.whi.2022.12.001","volume":"33","author":"JD Runkle","year":"2023","unstructured":"Runkle, J. D., Risley, K., Roy, M. & Sugg, M. M. Association Between Perinatal Mental Health and Pregnancy and Neonatal Complications: A Retrospective Birth Cohort Study. Womens Health Issues. 33, 289\u2013299 (2023).","journal-title":"Womens Health Issues"},{"key":"57533_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan, J. F., O\u2019Riordan, K. J., Sandhu, K., Peterson, V. & Dinan, T. G. The gut microbiome in neurological disorders. Lancet Neurol. 19, 179\u2013194 (2020).","journal-title":"Lancet Neurol."},{"key":"57533_CR38","doi-asserted-by":"publisher","first-page":"138665","DOI":"10.1016\/j.jhazmat.2025.138665","volume":"494","author":"J Feng","year":"2025","unstructured":"Feng, J. et al. Exposure of infants to antibiotics via cord blood, breast milk, and formula: A review on exposure level, temporal variation, and risk assessment. J. Hazard. Mater. 494, 138665 (2025).","journal-title":"J. Hazard. Mater."},{"key":"57533_CR39","doi-asserted-by":"publisher","unstructured":"Nakitanda AO, Kieler H, Odsbu I, Rhedin S, Almqvist C, Pasternak B, Pazzagli L. In-utero antibiotic exposure andsubsequent infections in infancy: a register-based cohort study with sibling analysis. Am J Obstet Gynecol MFM. 2023Apr;5(4):100860. Epub 2023 Jan 7. PMID: 36626967. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100860","DOI":"10.1016\/j.ajogmf.2023.100860"},{"key":"57533_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/dmcn.15643","volume":"66","author":"M Mynarek","year":"2024","unstructured":"Mynarek, M. et al. Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Dev. Med. Child. Neurol. 66, 125\u2013133 (2024).","journal-title":"Dev. Med. Child. Neurol."},{"key":"57533_CR41","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1034\/j.1600-0412.2003.00172.x","volume":"82","author":"O Axelsson","year":"2003","unstructured":"Axelsson, O. The Swedish medical birth register. Acta Obstet. Gynecol. Scand. 82, 491\u2013492 (2003).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"57533_CR42","unstructured":"Socialstyrelsen National Patient Register. (2022)."},{"key":"57533_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke, H. L. et al. The Swedish cause of death register. Eur. J. Epidemiol. 32, 765\u2013773 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"57533_CR44","doi-asserted-by":"publisher","unstructured":"Ha TCT, Orwa S, Guedes S, Moley K, Wannerberger K, Elfvin A, Blaser MJ, Gudnadottir U, Brusselaers N. Antibiotic useduring pregnancy and neonatal Group B Streptococcus disease. J Infect. 2026 Feb;92(2):106669. Epub 2025 Dec 29. PMID: 41475595. https:\/\/doi.org\/10.1016\/j.jinf.2025.106669","DOI":"10.1016\/j.jinf.2025.106669"},{"key":"57533_CR45","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. (2021).ATC\/DDD Index (2022)."},{"key":"57533_CR46","unstructured":"Region Stockholm. Grupp B Streptokocker (GBS). (2024)."},{"key":"57533_CR47","unstructured":"Socialstyrelsen Prevention Av Tidiga Infektioner Med Grupp B-Streptokocker (GBS) Hos Nyf\u00f6dda. (2008)."},{"key":"57533_CR48","unstructured":"Therneau, T. _A Package for Survival Analysis in R_. (2024)."},{"key":"57533_CR49","unstructured":"Yan [aut, L. & cre. ggvenn: Draw Venn Diagram by. \u2018ggplot2\u2019. (2023)."},{"key":"57533_CR50","unstructured":"RStudio Team. RStudio: Integrated Development for R. RStudio, PBC, Boston, MA (2020)."},{"key":"57533_CR51","doi-asserted-by":"crossref","unstructured":"Hadley Wickham. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York (2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"57533_CR52","unstructured":"Kassambara, A., Kosinski, M., Biecek, P. & Fabian, S. survminer: Drawing Survival Curves using \u2018ggplot2\u2019. (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57533-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57533-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:27:41Z","timestamp":1781195261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57533-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57533"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57533-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG, KM and KM were employed by Ferring Pharmaceuticals at the time this analysis was conducted. This RWE study was funded by Ferring Pharmaceuticals (to NB) yet led by the KI team. The Ferring-affiliated authors (SG, KM, and KW) contributed to the study design and interpretation of the results, but had no role in data collection, data management, statistical analyses, or drafting of the manuscript, and they did not have authority to halt, delay, or veto submission for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in accordance with the Declaration of Helsinki, and STROBE (Supplementary material), and with ethical approval from the Swedish Ethical Review Authority (2017\/2423-31). Informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"18192"}}